TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2504375

Group type: EXPERIMENTAL
Intervention: Restricted diet (avoiding milk and other dairy products, eggs, fish, peanuts, and soybeans) for mothers who breast fed
Number of subjects: 221

Group type: COMPARATOR
Intervention: Breast feeding without dietary restrictions
Number of subjects: 221

Group type: COMPARATOR
Intervention: Casein hydrolysate formula for infants not breast fed
Number of subjects: 221

Group type: COMPARATOR
Intervention: Soy milk formula for infants not breast fed
Number of subjects: 221

Group type: COMPARATOR
Intervention: Cows' milk formula for infants not breast fed
Number of subjects: 221
Study: 1221227

Group type: EXPERIMENTAL
Intervention: s.c. heparin and dextran 40 (small doses)
Number of subjects: 95
Study: 31377851

Group type: EXPERIMENTAL
Intervention: Low sodium diet (LNa, 15 mg kg‐1 day‐1)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Usual diet (UDiet, 46 (37-56) mg kg‐1 day‐1)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High sodium diet (HNa, 100 mg kg‐1 day‐1)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (Usual diet)
Number of subjects: 15
Study: 30235221

Group type: EXPERIMENTAL
Intervention: Daily self-report questionnaires
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Daily use of PA monitors (Fitbit One™)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Retention strategies (automated data collection, prorated incentive structure, dedicated study staff, 2-wave process)
Number of subjects: 50
Study: 25986296

Group type: COMPARATOR
Intervention: Massage therapy alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Massage therapy combined with meditation
Number of subjects: 40
Study: 25130518

Group type: EXPERIMENTAL
Intervention: Telecare management intervention
Number of subjects: 405

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 405
Study: 22458699

Group type: EXPERIMENTAL
Intervention: Warm up
Number of subjects: 12

Group type: COMPARATOR
Intervention: No warm up
Number of subjects: 12
Study: 19969618

Group type: EXPERIMENTAL
Intervention: Parent-child discussions about sexual topics
Number of subjects: 141
Study: 18654785

Group type: EXPERIMENTAL
Intervention: CE‐3D‐tFLASH
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: ECG/breath‐gated CE‐3D‐TrueFISP
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: CE‐3D‐TrueFISP
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 2D‐TrueFISP
Number of subjects: 31

Group type: COMPARATOR
Intervention: ECG/breath‐gated 3D‐TrueFISP
Number of subjects: 31
Study: 15716214

Group type: EXPERIMENTAL
Intervention: Zaleplon 5 and 10 mg nightly for 6 to 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (during the 7-day single-blind placebo-controlled run-out period)
Number of subjects: 0
Study: 12353407

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine (40 mL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.5% ropivacaine (40 mL) plus clonidine (40 micrograms)
Number of subjects: 30
Study: 9823343

Group type: EXPERIMENTAL
Intervention: Apraclonidine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Brimonidine
Number of subjects: 40
Study: 7613410

Group type: EXPERIMENTAL
Intervention: Structured assessment schedule taught to practitioners
Number of subjects: 440

Group type: COMPARATOR
Intervention: Control group (no structured assessment)
Number of subjects: 440
Study: 2584544

Group type: EXPERIMENTAL
Intervention: Structured laboratory setting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-directed self-taught modules
Number of subjects: 0
Study: 268268

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (vincristine, 6-mercaptopurine, hydroxyurea, prednisone)
Number of subjects: 16
Study: 7128841

Group type: EXPERIMENTAL
Intervention: Ortho‐Novum 1/50 tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ortho‐Novum 1/35 tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modicon tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lowest dose product (unspecified)
Number of subjects: 0
Study: 31389607

Group type: EXPERIMENTAL
Intervention: TACE combined with HIFU
Number of subjects: 100

Group type: COMPARATOR
Intervention: TACE (Control Group)
Number of subjects: 100
Study: 28885402

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA); given within 3 hours after delivery; specific dosage not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic TXA; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 27969026

Group type: EXPERIMENTAL
Intervention: Smartphone application (App) for self-care, used for 12 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: No smartphone application (Control group)
Number of subjects: 53
Study: 23768250

Group type: EXPERIMENTAL
Intervention: AVN-211 (CD-008-0173)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 22739133

Group type: EXPERIMENTAL
Intervention: PrePex (nonsurgical male circumcision)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Dorsal-slit method (surgical male circumcision)
Number of subjects: 217
Study: 19435740

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 125

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 125
Study: 17562974

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg daily
Number of subjects: 387

Group type: COMPARATOR
Intervention: Aliskiren 150 mg daily
Number of subjects: 387

Group type: COMPARATOR
Intervention: Aliskiren 300 mg daily
Number of subjects: 387
Study: 15330493

Group type: EXPERIMENTAL
Intervention: Hyben Vital 5 g daily
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 11931314

Group type: EXPERIMENTAL
Intervention: Informational maskers comprised of narrow-band sequences
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gaussian noise bursts
Number of subjects: 0

Group type: COMPARATOR
Intervention: No masker
Number of subjects: 0
Study: 9680674

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 7986974

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg/day for one week
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg/day for one week followed by clarithromycin 1 g/day for 2 weeks (group B)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg/day for one week followed by tripotassium dicitrato bismuthate 480 mg/day and clarithromycin 1 g/day for two weeks (group C)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Tripotassium dicitrato bismuthate 480 mg/day and clarithromycin 1 g/day for two weeks (group D)
Number of subjects: 88
Study: 2534839

Group type: EXPERIMENTAL
Intervention: Fentanyl 5 micrograms/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl 10 micrograms/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl with etomidat
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (0.9% saline solution)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Thiopentalum with fentanyl
Number of subjects: 60
Study: 1091148

Group type: EXPERIMENTAL
Intervention: Human placental lactogen (HPL) treatment group
Number of subjects: 2733

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2733
Study: 31814335

Group type: EXPERIMENTAL
Intervention: Enzyme Replacement Therapy (ERT) in CLN2 disease patients
Number of subjects: 21

Group type: COMPARATOR
Intervention: Neurofilament light levels before treatment in CLN2 disease patients
Number of subjects: 21

Group type: COMPARATOR
Intervention: Neurofilament light levels in TPP1-null dogs
Number of subjects: 21

Group type: COMPARATOR
Intervention: Neurofilament light levels in control dogs (TPP1+/− and WT)
Number of subjects: 21
Study: 28973619

Group type: EXPERIMENTAL
Intervention: Continuous oxygen for 72 hours (n=2668)
Number of subjects: 8003

Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen (21:00 to 07:00 hours) for 3 nights (n=2667)
Number of subjects: 8003

Group type: COMPARATOR
Intervention: Control (oxygen only if clinically indicated; n=2668)
Number of subjects: 8003
Study: 25499589

Group type: EXPERIMENTAL
Intervention: Mifepristone with one set of osmotic dilators plus misoprostol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Two sets of osmotic dilators plus misoprostol (control group)
Number of subjects: 50
Study: 24077199

Group type: EXPERIMENTAL
Intervention: Local anesthetic alone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Local anesthetic with steroids
Number of subjects: 120
Study: 20687845

Group type: EXPERIMENTAL
Intervention: CDA lotion (non-irritating hydrating lotion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CDA lotion (twice-daily application for 4 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CDA lotion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Currently available moisturizing products
Number of subjects: 0
Study: 19638365

Group type: EXPERIMENTAL
Intervention: Aggressive statin administration before percutaneous coronary intervention (PCI)
Number of subjects: 50
Study: 16762666

Group type: EXPERIMENTAL
Intervention: Visual feedback from load-time histories of their performance compared with a criterion standard
Number of subjects: 40

Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 40
Study: 15210501

Group type: EXPERIMENTAL
Intervention: Once daily (OD) gentamicin regimen
Number of subjects: 297

Group type: COMPARATOR
Intervention: Multi-dose (MD) gentamicin regimen
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Both OD and MD regimens
Number of subjects: 297
Study: 10027935

Group type: EXPERIMENTAL
Intervention: ACE inhibitor
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Calcium channel blocker
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (healthy volunteers)
Number of subjects: 9
Study: 8705090

Group type: EXPERIMENTAL
Intervention: Controlled release tablet of 300 mg theophylline
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intravenous dose equivalent to 131.46 mg theophylline
Number of subjects: 7
Study: 1324637

Group type: EXPERIMENTAL
Intervention: Daptomycin (3 mg/kg body weight)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Vancomycin (1,000 mg)
Number of subjects: 12
Study: 6706044

Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance
Number of subjects: 266

Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Plasma glucose concentration
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: 2‐h and fasting plasma glucose values
Number of subjects: 266
Study: 31152441

Group type: EXPERIMENTAL
Intervention: Lasmiditan 50 mg
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Lasmiditan (all doses)
Number of subjects: 4000
Study: 27810949

Group type: EXPERIMENTAL
Intervention: Multiple-source condition
Number of subjects: 2087

Group type: COMPARATOR
Intervention: Single-source condition
Number of subjects: 2087
Study: 27471209

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 5107

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 5107
Study: 25081651

Group type: EXPERIMENTAL
Intervention: Tiotropium 5 μg
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Tiotropium 1.25 μg
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Tiotropium 2.5 μg
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Tiotropium 5 μg, 1.25 μg, 2.5 μg
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 22044726

Group type: EXPERIMENTAL
Intervention: Tracheal intubation with an endotracheal tube
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oesophageal intubation using an Easytube(®)
Number of subjects: 40
Study: 20947881

Group type: COMPARATOR
Intervention: Clarithromycin sequential therapy
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Levofloxacin-250 sequential therapy
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Levofloxacin-500 sequential therapy
Number of subjects: 375
Study: 19006732

Group type: EXPERIMENTAL
Intervention: Femtosecond laser (IntraLase FS30)
Number of subjects: 146
Study: 15744778

Group type: EXPERIMENTAL
Intervention: Breast cancer survivors
Number of subjects: 184

Group type: COMPARATOR
Intervention: Age-matched controls
Number of subjects: 184
Study: 12548273

Group type: EXPERIMENTAL
Intervention: 3‐in‐1 nerve block with bupivacaine plus intravenous morphine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 50
Study: 11031221

Group type: EXPERIMENTAL
Intervention: Front-loaded regimen of clopidogrel (300 mg the first day and 75 mg/d for the next 7 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard regimen of clopidogrel (75 mg/d for 8 days)
Number of subjects: 20
Study: 8898135

Group type: EXPERIMENTAL
Intervention: Unscrubbed, ungowned leg holder during preparation and draping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Scrubbed and gowned leg holder during preparation and draping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General air counts during preparation and draping
Number of subjects: 0
Study: 1894672

Group type: EXPERIMENTAL
Intervention: Monochromatic ultraviolet radiation of 254 nm
Number of subjects: 113

Group type: COMPARATOR
Intervention: Ultra-clean air enclosure (Charnley‐Howorth air enclosure)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Occlusive clothing for all personnel
Number of subjects: 113
Study: 6360597

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg, administered orally 30 min prior to the test meal.
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Metoclopramide for patients with delayed gastric emptying.
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Metoclopramide for patients with normal gastric emptying.
Number of subjects: 26
Study: 31977907

Group type: EXPERIMENTAL
Intervention: Moxibustion (twice weekly for 4 weeks at acupuncture points SP6, LR3, and CV4) plus conventional medication for 4 weeks, followed by conventional medication alone for 8 weeks.
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Moxibustion plus conventional medication.
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional medication alone.
Number of subjects: 29
Study: 30885027

Group type: EXPERIMENTAL
Intervention: Multimodal intervention (dexmedetomidine 1 µg/kg IV 15 minutes before anesthesia induction and bilateral transversus abdominis plane block with 0.375% ropivacaine 30 mL)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 153
Study: 27613490

Group type: EXPERIMENTAL
Intervention: Radium-223
Number of subjects: 901

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 901
Study: 27466608

Group type: EXPERIMENTAL
Intervention: Orange maize delivering 600 μg retinol equivalents (REs)/d as carotenoid plus placebo (OM)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Low‐carotenoid white maize plus 600 μg REs/d as retinyl palmitate (VA)
Number of subjects: 149

Group type: COMPARATOR
Intervention: White maize plus placebo (WM)
Number of subjects: 149
Study: 25267740

Group type: EXPERIMENTAL
Intervention: Gemcitabine, dexamethasone, and cisplatin (GDP)
Number of subjects: 619

Group type: COMPARATOR
Intervention: Dexamethasone, cytarabine, and cisplatin (DHAP)
Number of subjects: 619
Study: 22710881

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sitting position
Number of subjects: 30
Study: 21036759

Group type: EXPERIMENTAL
Intervention: Irinotecan/fluorouracil/leucovorin (IRI/FU/LV)
Number of subjects: 417

Group type: COMPARATOR
Intervention: Irinotecan/fluorouracil/leucovorin followed by oxaliplatin/fluorouracil/leucovorin (IRI/FU/LV followed by OXA/FU/LV)
Number of subjects: 417
Study: 19159546

Group type: EXPERIMENTAL
Intervention: Multiplex quantitative fluorescent PCR (QF‐PCR)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Fluorescence in situ hybridization (FISH)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Ordinary PCR
Number of subjects: 4
Study: 16036165

Group type: EXPERIMENTAL
Intervention: Arnica montana C6 and Bellis perennis C6
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Arnica montana C30 and Bellis perennis C30
Number of subjects: 40

Group type: COMPARATOR
Intervention: Double placebo
Number of subjects: 40
Study: 12072066

Group type: EXPERIMENTAL
Intervention: Topical 0.1% methylprednisolone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical 0.5% dexpanthenol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical corticosteroid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexpanthenol-containing emollient
Number of subjects: 0
Study: 10500778

Group type: EXPERIMENTAL
Intervention: Quinine (30 mg/kg/day)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 131
Study: 8397459

Group type: EXPERIMENTAL
Intervention: buflomedil
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 3529538

Group type: EXPERIMENTAL
Intervention: Aspirin (25 mg/kg/day for 24 hours in four equally divided doses)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (starch, 25 mg/kg/day for 24 hours in four equally divided doses)
Number of subjects: 48
Study: 31725697

Group type: EXPERIMENTAL
Intervention: Reusable Acuvue 2 (A2)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Reusable Acuvue Oasys (AO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Daily disposable Acuvue Oasys (AODD)
Number of subjects: 20
Study: 29149755

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5mg/kg) plus propofol (0.5mg/kg)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Propofol (1mg/kg)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Ketamine plus propofol
Number of subjects: 77
Study: 25828946

Group type: EXPERIMENTAL
Intervention: Microincision coaxial cataract surgery
Number of subjects: 84

Group type: COMPARATOR
Intervention: Small incision coaxial cataract surgery
Number of subjects: 84
Study: 26056749

Group type: EXPERIMENTAL
Intervention: Dissonance-based prevention program
Number of subjects: 408

Group type: COMPARATOR
Intervention: Educational brochure control condition
Number of subjects: 408
Study: 23778412

Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg daily
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control (non-diabetic patients)
Number of subjects: 68
Study: 21337950

Group type: EXPERIMENTAL
Intervention: LouseBuster treatment by experienced operators
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: LouseBuster treatment by novice operators
Number of subjects: 56
Study: 19737424

Group type: EXPERIMENTAL
Intervention: Tailored education and coaching (TEC)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Educationally-enhanced usual care (EUC)
Number of subjects: 265
Study: 17013356

Group type: EXPERIMENTAL
Intervention: Acupuncture (stainless steel needle inserted to a depth of 20 mm, manually stimulated for 20 seconds)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham acupuncture (guide tube without a needle tapped on the skin)
Number of subjects: 31
Study: 12873325

Group type: EXPERIMENTAL
Intervention: LifeSPAN therapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 56
Study: 11134127

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes patients
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Type 1 diabetes patients
Number of subjects: 26

Group type: COMPARATOR
Intervention: Normal subjects (control for type 1)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Normal subjects (control for type 2)
Number of subjects: 26
Study: 9533167

Group type: EXPERIMENTAL
Intervention: Antidepressant therapy administered once every one or two weeks or several-times-daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antidepressant therapy (general)
Number of subjects: 0
Study: 7999650

Group type: EXPERIMENTAL
Intervention: Epidural alfentanil 500 micrograms in 10 mL 0.125% bupivacaine, followed by continuous infusion of alfentanil 20 micrograms/mL in 0.125% bupivacaine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fentanyl 50 micrograms in 10 mL 0.125% bupivacaine, followed by continuous infusion of fentanyl 2 micrograms/mL in 0.125% bupivacaine
Number of subjects: 24
Study: 3177951

Group type: EXPERIMENTAL
Intervention: Calcium dobesilate
Number of subjects: 30
Study: 30278457

Group type: EXPERIMENTAL
Intervention: 1100F/HMPnano
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1100F/HMP
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29231338

Group type: EXPERIMENTAL
Intervention: Acupuncture at zygapophyseal joint, transverse process, superior gluteus nerve into the hip point, and Weizhong (BL 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional acupuncture at Qihaishu (BL 24), Jiaji (EX-B 2) of L2-L4, superior gluteus nerve into the hip point, and Weizhong (BL 40)
Number of subjects: 80
Study: 25882438

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) - 3 injections of 1 mL
Number of subjects: 50

Group type: COMPARATOR
Intervention: Hyaluronic Acid (HA) - 3 injections of 1 mL
Number of subjects: 50
Study: 23127590

Group type: EXPERIMENTAL
Intervention: PGS+
Number of subjects: 188

Group type: COMPARATOR
Intervention: PGS‐
Number of subjects: 188

Group type: COMPARATOR
Intervention: Reference group
Number of subjects: 188
Study: 20705281

Group type: EXPERIMENTAL
Intervention: Meridian-tapping (MT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Progressive muscle relaxation (PMR)
Number of subjects: 70
Study: 18512510

Group type: EXPERIMENTAL
Intervention: All‐Bond 2 (TE3) + resin cement post (rcp) + Duo‐link (Dl)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: One‐Step Plus (TE2) + rcp + Dl
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tyrian/One‐Step Plus (SE) + rcp + Dl
Number of subjects: 30
Study: 16497625

Group type: EXPERIMENTAL
Intervention: Magnification endoscopy with 1.5% acetic acid (A1 evaluation)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Magnification endoscopy with 1.5% acetic acid (A2 evaluation)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Evaluation by inexperienced investigators
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Evaluation by experienced investigators
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Inter-observer variability
Number of subjects: 60
Study: 14605329

Group type: EXPERIMENTAL
Intervention: tPA treatment
Number of subjects: 61
Study: 10919021

Group type: EXPERIMENTAL
Intervention: Endoscopic injection sclerotherapy with ligation (EISL)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Endoscopic injection sclerotherapy (EIS)
Number of subjects: 24